Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT01286805
Eligibility Criteria:
Inclusion Criteria:
* American Society of Anesthesiologists (ASA) Class 1-3
* Patients aged 18 to 65 years
* Patients scheduled for primary, unilateral arthroscopic hip surgery by Dr. Kelly, Dr. Coleman, or Dr. Anil Ranawat
* Planned use of neuraxial anesthesia
* Body Mass Index less than 35
* Ability to follow study protocol
Exclusion Criteria:
* Chronic opioid use (defined as daily or almost daily use of opioids for \>3 months)
* Contraindication to combined spinal-epidural anesthesia including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities.
* Contraindication to lumbar plexus block including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities.
* Infection at the injection site(s)
* Allergy to any of the study medications
* Contraindication to a short course of NSAIDs (renal failure, intolerance)
* ASA Class 4-5
* Patient refusal
* Patients younger than 18 years old and older than 65
* Patients with any known indwelling hardware of the lumbar spine.
* Patients with a peripheral neuropathy of the surgical extremity
* Non-English speaking patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01286805
Study Brief:
Protocol Section:
NCT01286805